BioauraHealth Official Website
Category: Pen Injector

3ml Cartridge Compatible Disposable Injector Pen

  • Universal 3mL Cartridge Compatibility: Optimized for standard 3mL cartridges, providing a versatile housing for various high-value medications.
  • High-Precision Dosing Mechanism: Features a minimum step size of 0.01mL, allowing for ultra-fine adjustments between 0.01mL and 0.6mL to ensure absolute dosage accuracy.
  • Enhanced Patient Comfort: Engineered with an ergonomic focus, utilizing a low-force delivery system (<5N for specific units) to minimize injection resistance and improve the user experience.
  • Broad Therapeutic Application: Primarily utilized for Weight Loss, Diabetes, and Endocrinology, supporting medications such as Semaglutide, Tirzepatide, and Insulin.
  • Global Compliance & Scalable Supply: Fully compliant with CE and MDR standards, with FDA (510k) submission in progress, supported by a robust manufacturing capacity of 1 billion units per year.

Description

Bioaura BH0001-SP: High-Precision Smart Auto Injector for Global Drug Delivery

  • The Bioaura BH0001-SP is a state-of-the-art smart auto injector designed to meet the rigorous demands of modern clinical drug delivery. As a versatile drug delivery device, it is engineered for the subcutaneous injection of critical biological medications, offering seamless compatibility with 3mL cartridges. This pen injector platform provides a precise dosage range from 0.01ml up to 0.6ml, ensuring maximum dosing flexibility for various therapeutic protocols across a wide spectrum of patient requirements.
  • Optimized for high-viscosity treatments, the BH0001-SP is the premier auto injection pen choice for advanced medications such as Semaglutide, Tirzepatide, and Insulin. It serves as an essential injector pen across critical healthcare fields including Weight Loss, Diabetes management, and Endocrinology. Patient comfort is significantly enhanced through its ergonomic design and an ultra-low pressing force of less than 5N, all supported by professional R&D data validation and rigorous quality control.
  • The auto injector pen maintains world-class safety profiles with CE and MDR certifications and active FDA (510k) submission. Boasting a massive current production capacity of 1 billion units per year, Bioaura ensures a reliable, scalable, and globally compliant supply chain for pharmaceutical partners worldwide. Choose the BH0001-SP for a patient-centric, high-precision solution in the evolving landscape of subcutaneous medication delivery.
Category Technical Specifications Details
Basic Info Model NO. BH0001-SP
Device Type Smart Auto Injector / Drug Delivery Device
Application Type Subcutaneous Injection (External Use)
Container Compatibility 3mL Cartridges
Dosing & Precision Dosage Range 0.01ml (Min) to 0.6ml (Max)
Customizable Units Available in 36/37/50/60/74/75/80 units
Injection Accuracy Professional R&D with data validation support
Mechanical Specs Pressing Force <5N (36/37 units) / <8N (74/80 units)
Pen Size 173mm * Φ 19.57mm
HS Code 9018310000
Regulatory & Safety Certification Status CE, MDR, FDA (510k) Submitted, CDE, FTO Review
Safety Profile No Side Effects (Device-related)
Therapeutic Areas Applicable Drugs Semaglutide, Tirzepatide, Insulin, Liraglutide, FSH
Target Fields Weight Loss, Diabetes, Endocrinology, Fertility
Manufacturing Production Capacity 1 Billion Units / Year Currently
Origin China (Bioaura Global Standard)

Robust 75 units delivery system for large volume subcutaneous drug injection Specific 37 units delivery device for targeted GLP-1 and diabetes therapies Medical grade 50 units injector pen compatible with standard 3ml cartridges

Product Dosage Unit Item No. Cartridge (Min. Step Size) Dosage Scale (Common Dosage) Primary Applicable Drugs
Multi-dose Autoinjector 8 U BH0008-D 3.0 mL (0.01 mL) 0–8 (Full scale)
3.0 mL (0.005 mL) 0–80
19 U BH0019-D 3.0 mL (0.01 mL) 0–0.25 mg
30 U BH0030-D 3.0 mL (0.01 mL) 0–0.6, 1.2, 1.8 mg
36 U BH0036-D 3.0 mL (0.0208 mL) 0–450 IU (Full scale) Follicle-Stimulating Hormone (FSH)
37 U BH0037-D 3.0 mL (0.01 mL) 0–0.25 mg, 0.5 mg, 0.25–0.5 mg Semaglutide (at 1.34mg/mL concentration)
50 U BH0050-D 3.0 mL (0.01 mL) 0–0.6, 1.2, 1.8, 2.4, 3.0 mg Liraglutide Injection
60 U BH0060-D 3.0 mL (0.01 mL) 0–60 (Full scale), 0–1 Insulin Aspart and Insulin Glargine series
70 U BH0070-D 3.0 mL (0.01428 mL) 0–700 (Full scale)
72 U BH0072-D 3.0 mL (0.01 mL) 0–450 IU (Full scale)
74 U BH0074-D 3.0 mL (0.01 mL) 0.25–0.5 mg, 0.25–0.5–1.0 mg, 0–2.0 mg, 0–1.0 mg Insulin Aspart/Glargine series; Semaglutide (multiple concentrations)
75 U BH0075-D 3.0 mL (0.01 mL) 0–1.0 mg, 0–1.7 mg, 0–2.4 mg, 0–2.0 mg, 0–1.7–2.4 mg, 0–2.5–5–10 mg, 0–1 Semaglutide series
80 U BH0080-D 3.0 mL (0.01 mL) 0–80 (Full scale) Insulin Degludec and Insulin Aspart series
3.0 mL (0.0067 mL) /
1.5 mL (0.0033 mL) /
100 U BH0100-D 3.0 mL (0.01 mL) 0–30 (Full scale), 0–50 (Full scale)

EXPLORE MORE SOLUTIONS

Discover our full range of high-precision auto injectors and smart drug delivery platforms.

VIEW PRODUCT CATALOGUE